Simon Nicholas
Insider CIK 1431403 · ACHN Director, 10% owner · GMED · AERI 10% owner · TLOG 10% owner · HAIR 10% owner · OPHT 10% owner · SIEN Director, 10% owner · OXFD 10% owner · GRTS Director, 10% owner · FTSV 10% owner · ETTX 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SIEN Sientra, Inc. | A Award | 2021-06-10 | 2021-06-15 | 16,870 | — | $0 | 101,569 | SEC↗ |
| GRTS Gritstone Oncology, Inc. | A Award deriv | 2020-06-18 | 2020-06-22 | 12,500 | — | $0 | 12,500 | SEC↗ |
| SIEN Sientra, Inc. | A Award | 2020-06-05 | 2020-06-09 | 27,717 | — | $0 | 84,699 | SEC↗ |
| GRTS Gritstone Oncology, Inc. | A Award deriv | 2019-06-19 | 2019-06-20 | 8,570 | — | $0 | 8,570 | SEC↗ |
| SIEN Sientra, Inc. | A Award | 2019-06-14 | 2019-06-18 | 19,320 | — | $0 | 56,982 | SEC↗ |
| GRTS Gritstone Oncology, Inc. | C Conversion deriv | 2018-10-02 | 2018-10-02 | 668,896 | — | $0 | 0 | SEC↗ |
| GRTS Gritstone Oncology, Inc. | C Conversion deriv | 2018-10-02 | 2018-10-02 | 1,565,216 | — | $0 | 0 | SEC↗ |
| GRTS Gritstone Oncology, Inc. | C Conversion | 2018-10-02 | 2018-10-02 | 2,234,112 | — | $0 | 2,567,445 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion deriv | 2018-09-28 | 2018-10-02 | 6,702,213 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion deriv | 2018-09-28 | 2018-10-02 | 8,552,024 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion deriv | 2018-09-28 | 2018-10-02 | 7,500,000 | — | $0 | 0 | SEC↗ |
| GRTS Gritstone Oncology, Inc. | P Buy | 2018-09-28 | 2018-10-02 | 333,333 | $15.00 | $5.00M | 333,333 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion | 2018-09-28 | 2018-10-02 | 361,829 | — | $0 | 361,829 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | P Buy | 2018-09-28 | 2018-10-02 | 453,395 | $15.00 | $6.80M | 1,623,405 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion | 2018-09-28 | 2018-10-02 | 412,583 | — | $0 | 1,170,010 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion | 2018-09-28 | 2018-10-02 | 323,341 | — | $0 | 685,170 | SEC↗ |
| FTSV Forty Seven, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-02 | 755,780 | — | $0 | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-02 | 938,489 | — | $0 | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-02 | 1,922,682 | — | $0 | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | C Conversion | 2018-07-02 | 2018-07-02 | 1,922,682 | — | $0 | 3,616,951 | SEC↗ |
| FTSV Forty Seven, Inc. | P Buy | 2018-07-02 | 2018-07-02 | 200,000 | $16.00 | $3.20M | 3,816,951 | SEC↗ |
| FTSV Forty Seven, Inc. | C Conversion | 2018-07-02 | 2018-07-02 | 938,489 | — | $0 | 938,489 | SEC↗ |
| FTSV Forty Seven, Inc. | C Conversion | 2018-07-02 | 2018-07-02 | 755,780 | — | $0 | 1,694,269 | SEC↗ |
| SIEN Sientra, Inc. | A Award | 2018-06-05 | 2018-06-07 | 6,116 | $20.44 | $125.0K | 37,662 | SEC↗ |
| HAIR Restoration Robotics Inc | C Conversion deriv | 2017-10-16 | 2017-10-17 | 3,389,105 | — | $0 | 0 | SEC↗ |
| HAIR Restoration Robotics Inc | C Conversion deriv | 2017-10-16 | 2017-10-17 | 0 | — | $0 | 0 | SEC↗ |
| HAIR Restoration Robotics Inc | C Conversion | 2017-10-16 | 2017-10-17 | 180,881 | $7.00 | $1.27M | 3,569,986 | SEC↗ |
| HAIR Restoration Robotics Inc | C Conversion | 2017-10-16 | 2017-10-17 | 3,389,105 | — | $0 | 3,389,105 | SEC↗ |
| HAIR Restoration Robotics Inc | J Other deriv | 2017-10-11 | 2017-10-13 | 0 | $1259269.79 | $0 | 0 | SEC↗ |
| SIEN Sientra, Inc. | A Award | 2017-06-22 | 2017-06-26 | 12,861 | $9.72 | $125.0K | 31,546 | SEC↗ |
| SIEN Sientra, Inc. | A Award | 2016-06-23 | 2016-06-27 | 18,685 | $6.69 | $125.0K | 18,685 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | S Sale | 2016-02-09 | 2016-02-10 | 230,507 | $0.16 | $36.9K | 2,214,523 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | S Sale | 2016-02-08 | 2016-02-10 | 103,123 | $0.19 | $19.6K | 2,445,030 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | S Sale | 2016-02-05 | 2016-02-05 | 832,881 | $0.20 | $166.6K | 2,548,153 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | S Sale | 2016-02-04 | 2016-02-05 | 500,026 | $0.14 | $70.0K | 3,381,034 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | S Sale | 2016-02-03 | 2016-02-05 | 82,583 | $0.15 | $12.4K | 3,881,060 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | S Sale | 2016-02-02 | 2016-02-02 | 176,306 | $0.17 | $30.0K | 3,963,643 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | S Sale | 2016-02-01 | 2016-02-02 | 140,000 | $0.20 | $28.0K | 4,139,949 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | S Sale | 2016-01-29 | 2016-02-02 | 52,826 | $0.26 | $13.7K | 4,279,949 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | S Sale | 2016-01-28 | 2016-01-28 | 32,521 | $0.26 | $8.5K | 4,332,775 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | S Sale | 2016-01-27 | 2016-01-28 | 209,984 | $0.27 | $56.7K | 4,365,296 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | S Sale | 2016-01-26 | 2016-01-28 | 69,425 | $0.30 | $20.8K | 4,575,280 | SEC↗ |
| SIEN Sientra, Inc. | A Award deriv | 2015-06-26 | 2015-08-17 | 7,037 | — | $0 | 7,037 | SEC↗ |
| OXFD Oxford Immunotec Global PL | S Sale | 2015-06-16 | 2015-06-17 | 39,701 | $14.30 | $567.7K | 2,237,377 | SEC↗ |
| OXFD Oxford Immunotec Global PL | S Sale | 2015-06-15 | 2015-06-17 | 1,529 | $14.27 | $21.8K | 2,277,078 | SEC↗ |
| OXFD Oxford Immunotec Global PL | S Sale | 2015-06-12 | 2015-06-12 | 6,430 | $14.25 | $91.6K | 2,278,607 | SEC↗ |
| OXFD Oxford Immunotec Global PL | S Sale | 2015-06-11 | 2015-06-12 | 25,168 | $14.27 | $359.1K | 2,285,037 | SEC↗ |
| OXFD Oxford Immunotec Global PL | S Sale | 2015-06-10 | 2015-06-10 | 8,987 | $14.32 | $128.7K | 2,310,205 | SEC↗ |
| OXFD Oxford Immunotec Global PL | S Sale | 2015-06-09 | 2015-06-10 | 13,000 | $14.26 | $185.4K | 2,319,192 | SEC↗ |
| OXFD Oxford Immunotec Global PL | S Sale | 2015-06-08 | 2015-06-10 | 2,662 | $14.25 | $37.9K | 2,332,192 | SEC↗ |
| OXFD Oxford Immunotec Global PL | S Sale | 2015-06-03 | 2015-06-03 | 10,450 | $14.32 | $149.6K | 2,334,854 | SEC↗ |
| OXFD Oxford Immunotec Global PL | S Sale | 2015-06-02 | 2015-06-03 | 11,014 | $14.25 | $156.9K | 2,345,304 | SEC↗ |
| OXFD Oxford Immunotec Global PL | S Sale | 2015-06-01 | 2015-06-03 | 15,010 | $14.29 | $214.5K | 2,356,318 | SEC↗ |
| OPHT Ophthotech Corp. | J Other | 2015-05-26 | 2015-05-28 | 1,554,744 | — | $0 | 0 | SEC↗ |
| OXFD Oxford Immunotec Global PL | S Sale | 2015-03-23 | 2015-03-24 | 26,300 | $14.44 | $379.8K | 2,371,328 | SEC↗ |
| OXFD Oxford Immunotec Global PL | S Sale | 2015-03-20 | 2015-03-24 | 27,115 | $14.53 | $394.0K | 2,397,628 | SEC↗ |
| OXFD Oxford Immunotec Global PL | S Sale | 2015-03-19 | 2015-03-19 | 50,012 | $14.61 | $730.7K | 2,424,743 | SEC↗ |
| OXFD Oxford Immunotec Global PL | S Sale | 2015-03-18 | 2015-03-19 | 25,000 | $14.68 | $367.0K | 2,474,755 | SEC↗ |
| OXFD Oxford Immunotec Global PL | S Sale | 2015-03-17 | 2015-03-19 | 79,307 | $14.67 | $1.16M | 2,499,755 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | J Other | 2015-01-28 | 2015-01-30 | 3,139,447 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2015-01-08 | 2015-01-12 | 175,000 | $31.11 | $5.44M | 3,324,259 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2015-01-05 | 2015-01-06 | 10,200 | $31.11 | $317.3K | 3,499,259 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2015-01-05 | 2015-01-06 | 13,420 | $30.67 | $411.6K | 3,509,459 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2014-12-29 | 2014-12-30 | 6,214 | $30.03 | $186.6K | 3,522,879 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2014-12-26 | 2014-12-30 | 74,510 | $30.05 | $2.24M | 3,529,093 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2014-12-23 | 2014-12-24 | 263 | $30.00 | $7.9K | 3,603,603 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2014-12-22 | 2014-12-24 | 49,441 | $30.36 | $1.50M | 3,603,866 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | A Award deriv | 2014-06-11 | 2014-06-16 | 13,500 | — | $0 | 13,500 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2014-06-11 | 2014-06-11 | 29,217 | $44.53 | $1.30M | 2,843,564 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2014-06-11 | 2014-06-11 | 500 | $44.32 | $22.2K | 4,500 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2014-06-10 | 2014-06-11 | 79,824 | $44.66 | $3.56M | 2,909,861 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2014-06-10 | 2014-06-11 | 36,880 | $45.90 | $1.69M | 2,872,981 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2014-06-10 | 2014-06-11 | 200 | $46.80 | $9.4K | 2,872,781 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2014-06-09 | 2014-06-11 | 25,697 | $46.02 | $1.18M | 3,029,047 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2014-06-09 | 2014-06-11 | 39,362 | $46.78 | $1.84M | 2,989,685 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion deriv | 2013-12-17 | 2013-12-19 | 853,416 | — | $0 | 0 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | X Exercise deriv | 2013-12-17 | 2013-12-19 | 23,282 | $6.40 | $149.0K | 0 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion deriv | 2013-12-17 | 2013-12-19 | 2,342,944 | — | $0 | 0 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | X Exercise | 2013-12-17 | 2013-12-19 | 23,282 | $6.40 | $149.0K | 4,644,705 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | P Buy | 2013-12-17 | 2013-12-19 | 1,425,063 | $7.00 | $9.98M | 1,425,063 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion | 2013-12-17 | 2013-12-19 | 853,416 | $7.00 | $5.97M | 4,621,423 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion | 2013-12-17 | 2013-12-19 | 2,342,944 | — | $0 | 3,768,007 | SEC↗ |
| OXFD Oxford Immunotec Global PL | C Conversion deriv | 2013-11-22 | 2013-11-25 | 203,439 | — | $0 | 0 | SEC↗ |
| OXFD Oxford Immunotec Global PL | C Conversion deriv | 2013-11-22 | 2013-11-25 | 553,859 | — | $0 | 0 | SEC↗ |
| OXFD Oxford Immunotec Global PL | C Conversion deriv | 2013-11-22 | 2013-11-25 | 1,239,308 | — | $0 | 0 | SEC↗ |
| OXFD Oxford Immunotec Global PL | C Conversion deriv | 2013-11-22 | 2013-11-25 | 582,456 | — | $0 | 0 | SEC↗ |
| OXFD Oxford Immunotec Global PL | C Conversion | 2013-11-22 | 2013-11-25 | 582,456 | — | $0 | 582,456 | SEC↗ |
| OXFD Oxford Immunotec Global PL | C Conversion | 2013-11-22 | 2013-11-25 | 1,239,308 | — | $0 | 1,821,764 | SEC↗ |
| OXFD Oxford Immunotec Global PL | C Conversion | 2013-11-22 | 2013-11-25 | 553,859 | — | $0 | 2,375,623 | SEC↗ |
| OXFD Oxford Immunotec Global PL | C Conversion | 2013-11-22 | 2013-11-25 | 203,439 | — | $0 | 2,579,062 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion deriv | 2013-10-25 | 2015-01-30 | 184,812 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion deriv | 2013-10-25 | 2015-01-30 | 184,812 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2013-10-25 | 2015-01-30 | 321,000 | $10.00 | $3.21M | 3,468,494 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion deriv | 2013-10-25 | 2013-10-28 | 420,222 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion deriv | 2013-10-25 | 2013-10-28 | 2,727,272 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion deriv | 2013-10-25 | 2013-10-28 | 184,812 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion | 2013-10-25 | 2013-10-28 | 420,222 | — | $0 | 3,147,494 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion | 2013-10-25 | 2013-10-28 | 184,812 | $0.05 | $9.2K | 3,332,306 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2013-10-25 | 2013-10-28 | 321,000 | $10.00 | $3.21M | 3,653,306 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion | 2013-10-25 | 2013-10-28 | 2,727,272 | — | $0 | 2,727,272 | SEC↗ |
| OPHT Ophthotech Corp. | C Conversion deriv | 2013-09-30 | 2013-10-02 | 2,542,373 | — | $0 | 0 | SEC↗ |
| OPHT Ophthotech Corp. | C Conversion deriv | 2013-09-30 | 2013-10-02 | 186,027 | — | $0 | 0 | SEC↗ |
| OPHT Ophthotech Corp. | C Conversion | 2013-09-30 | 2013-10-02 | 186,027 | — | $0 | 2,728,390 | SEC↗ |
| OPHT Ophthotech Corp. | C Conversion | 2013-09-30 | 2013-10-02 | 2,542,373 | — | $0 | 2,542,373 | SEC↗ |
| GMED GLOBUS MEDICAL INC | J Other | 2013-09-03 | 2013-09-04 | 7,244,201 | — | $0 | 0 | SEC↗ |
| GMED GLOBUS MEDICAL INC | C Conversion deriv | 2012-08-08 | 2012-08-10 | 7,444,168 | — | $0 | 0 | SEC↗ |
| GMED GLOBUS MEDICAL INC | S Sale | 2012-08-08 | 2012-08-10 | 804,232 | $11.16 | $8.98M | 7,244,201 | SEC↗ |
| GMED GLOBUS MEDICAL INC | C Conversion | 2012-08-08 | 2012-08-10 | 7,444,168 | — | $0 | 8,048,433 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | J Other | 2012-06-04 | 2012-06-06 | 22,078 | — | $0 | 22,078 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | J Other | 2012-06-04 | 2012-06-06 | 51,515 | — | $0 | 51,515 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | X Exercise deriv | 2012-05-31 | 2012-06-04 | 1,290,922 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | X Exercise deriv | 2012-05-31 | 2012-06-04 | 1,706,426 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | X Exercise | 2012-05-31 | 2012-06-04 | 1,290,922 | $3.53 | $4.56M | 10,553,001 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2012-05-31 | 2012-06-04 | 708,810 | $7.49 | $5.31M | 10,942,471 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | X Exercise | 2012-05-31 | 2012-06-04 | 1,706,426 | $3.11 | $5.31M | 12,259,427 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2012-05-31 | 2012-06-04 | 608,146 | $7.49 | $4.56M | 11,651,281 | SEC↗ |